State Street® SPDR® S&P® Biotech ETF XBI

Medalist Rating as of | See State Street Investment Hub

Morningstar’s Analysis XBI

Will XBI outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

State Street® SPDR® S&P® Biotech ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings XBI

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 17.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

2.44 252M
Healthcare

Twist Bioscience Corp

1.87 193M
Healthcare

Natera Inc

1.79 184M
Healthcare

Iovance Biotherapeutics Inc

1.64 169M
Healthcare

AbbVie Inc

1.62 167M
Healthcare

United Therapeutics Corp

1.60 164M
Healthcare

Biogen Inc

1.58 163M
Healthcare

Amgen Inc

1.56 161M
Healthcare

Gilead Sciences Inc

1.53 158M
Healthcare

Halozyme Therapeutics Inc

1.51 156M
Healthcare

Sponsor Center